Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Finasteride, CPA, and flutamide are all equally effective in reducing excessive hair growth in women.

PCOS in teens is hard to diagnose, linked to genetics and lifestyle, and managed with weight loss and medication.

Human hair follicles produce and respond to erythropoietin, helping protect against stress.

Polycystic Ovary Syndrome is linked to higher risk of hypertension and heart disease.

Certain drugs that block specific enzymes can help treat prostate diseases.

Prolactin may play a significant role in skin and hair health and could be a target for treating skin and hair disorders.

Eating healthy, exercising, and taking certain supplements can help manage Polycystic Ovary Syndrome symptoms.

Dietary changes, including weight loss and a balanced diet, are important for managing PCOS, especially in overweight women.

The document concludes that correct diagnosis and management of PCOS are important, and more research is needed on its risks and treatments.

Finasteride effectively reduces hair growth in women with polycystic ovary syndrome or idiopathic hirsutism.

The conclusion is that accurately identifying the cause of high androgen levels in women with PCOS is crucial and requires specific tests.

High doses of finasteride cause cell growth and tumors in mice.

Women with polycystic ovary syndrome tend to have a longer anogenital distance.

Finasteride and minoxidil are effective FDA-approved treatments for androgenetic alopecia.

The document concludes that managing hirsutism involves identifying the cause, using a scoring system for severity, combining cosmetic and medical treatments, encouraging weight loss, and providing psychological support, while noting the need for more research on drug treatments.

Certain genetic variations are linked to increased androgen levels in PCOS, but more research is needed to understand these connections fully.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

Hirsute women have lower type 2 17β-HSD enzyme levels, which improve with treatment.

Finasteride significantly reduces hair growth in women with idiopathic hirsutism.

The document says that understanding the causes of PCOS is important for treatment, especially in distinguishing the syndrome from just having cystic ovaries, and that losing weight is key for obese women with PCOS.

Oral contraceptives lower testosterone levels in women, especially those with certain genetic traits, and may be linked to increased breast cancer risk.

Testosterone affects brain functions and contributes to sex differences, influencing conditions like autism.

Androgens affect bone and fat cell development differently based on the cells' embryonic origin.

The document concludes that various drugs can manage symptoms and metabolic issues in women with PCOS.

Adrenal gland disease is common in ferrets and causes hair loss and other symptoms.

Effective hirsutism management requires identifying the cause, combining new and traditional treatments, and setting realistic expectations for patients.

Treating excessive hair in women requires a holistic approach, including medical, aesthetic, and emotional support.

Women with congenital adrenal hyperplasia have lower fertility, but with proper treatment, they can conceive successfully.

New treatments for excessive hair growth in women include insulin modulators and enzyme inhibitors.

Alternative treatments show promise for hair growth beyond traditional methods.